← All news

FROM THE NEWS FEED

After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data

2026-02-20 • Psychedelic Alpha

Article summary

Researchers, clinicians and executives react to Compass Pathways’ second positive Phase 3 psilocybin readout in treatment-resistant depression.

Continue to the original publication for the complete article.